[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Jazz Pharmaceuticals, Inc. (JAZZ)
Jazz Pharmaceuticals receives FDA approval for Zepzelca combination in lung cancer treatment. Stock price down despite positive news, likely due to earnings concerns and market competition.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. (JAZZ) is a pharmaceutical company focused on developing and commercializing medicines.
Jazz Pharmaceuticals, Inc. uses the ticker $JAZZ for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Jazz Pharmaceuticals, Inc. (JAZZ) social dominance is up XXXXXX% from the previous month.
- Jazz Pharmaceuticals, Inc. (JAZZ) sentiment is up XX% from the previous week.
Price: $XXXXXX #
Price 24-Hour Time-Series Raw Data
The stock price is down -XXXX% in the last XX hours, likely due to the earnings miss and increased competition, despite positive developments in the product pipeline and regulatory approvals.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXXX% | -XXXX% | XXXX% |
1-Year High: $XXXXXX on 2025-02-26
1-Year Low: $XXXXX on 2025-05-09
AltRank: XXXXX #
AltRank 24-Hour Time-Series Raw Data
Jazz Pharmaceuticals, Inc. (JAZZ) is currently AltRank #2,015 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX +231
1 Month: XXXXX +364
6 Months: XXXXX +1,517
1 Year: XXXXX +807
1-Year High: XXXXX on 2025-09-04
1-Year Low: XXX on 2025-05-14
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -X
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-02-24
1-Year Low: XX on 2025-07-31
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX +312%
6 Months: XXXXXXXXX +64%
1 Year: XXXXXXXXX +46%
1-Year High: XXXXXXX on 2025-10-02
1-Year Low: XX on 2025-09-16
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXX -XX%
6 Months: XXXXX +13%
1 Year: XXXXX +128%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-16
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Jazz Pharmaceuticals, Inc. (JAZZ) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX +68%
1 Year: XXXXX +219%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-16
The most influential creators that mention Jazz Pharmaceuticals, Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @mikeycolombia33 | X | XXXXX | XX | XXX |
| @Quantumup1 | X | XXXXX | X | XX |
| @Biobeats99 | X | XXX | X | XX |
| @NightOwlBiotech | X | XXXXX | X | XX |
| @highnihilism | X | XXX | X | X |
Sentiment: XXX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% +20%
1 Month: XXX% no change
6 Months: XXX% +31%
1 Year: XXX% +67%
1-Year High: XXX% on 2025-02-20
1-Year Low: XX% on 2025-02-01
Most Supportive Themes
- Positive Regulatory News and Approvals: (35%) Posts highlight positive regulatory events, such as FDA approvals for generic versions of Jazz Pharmaceuticals' drugs.
- Analyst Recommendations and Price Targets: (25%) Mentions of analyst ratings and price targets, which can influence investor sentiment and trading activity.
- Product Pipeline and Clinical Trials: (20%) Positive mentions of Jazz Pharmaceuticals' product pipeline, including Modeyso (dordaviprone) and its inclusion in NCCN guidelines.
Most Critical Themes
- Competition and Market Dynamics: (20%) Mentions of competition in the narcolepsy market, such as Avadel's Lumryz, and the impact on Jazz Pharmaceuticals' market share.
- Earnings Miss and Financial Performance: (10%) The company faced a miss in earnings expectations, with non-GAAP EPS of $1.68, which could be a concern for investors.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XXX | XX% | X | X% |
| Total | XXX | XX% | XXX | XX% | X | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXX% +0.0036%
1 Month: XXXXX% +0.0098%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% +0.0077%
1-Year High: XXXXX% on 2024-11-22
1-Year Low: XXXXXX% on 2025-09-16
Market Dominance: XXXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-08-06
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$2.60%
1 Month: $XXXXXXXXXXXXX +$6.10%
6 Months: $XXXXXXXXXXXXX +$30%
1 Year: $XXXXXXXXXXXXX +$18%
1-Year High: $XXXXXXXXXXXXX on 2025-02-26
1-Year Low: $XXXXXXXXXXXXX on 2025-05-09
Top assets mentioned In the posts about Jazz Pharmaceuticals, Inc. in the last XX hours
Pfizer, Inc. (PFE) Johnson & Johnson (JNJ) Johnson & Johnson (JNJ) Merck & Co., Inc. (MRK) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Incyte Corporation (INCY) BioMarin Pharmaceutical, Inc. (BMRN) Alkermes Inc. plc (ALKS) Apellis Pharmaceuticals, Inc. Common Stock (APLS)
Top topics mentioned In the posts about Jazz Pharmaceuticals, Inc. in the last XX hours
stocks healthcare, $pfe, johnson johnson, $jnj, $mrk, $mdgl, $adhcon, $adhc0015, $incy, coins solana ecosystem, $adhc, $adhcfda, $adhc0016, $bmrn, $alks, $apls, $bhvn, $acad, investment, coins stablecoin, superrare, superrarebears, coins dao, stocks industrials, approved, $idya, $inbx, $axsm, $arvn, $bcax, $hznp, $itci, $bpmc, $bivv, $350mm, $sndx, $rigl, $drug, $ewtx, dyne therapeutics, $dyn, $bntx, coins defi, coins nft, $plug, infrastructure, $425m, $sanionst, $arqt, $amgn, $onc, $urgn, $lh, $qubt, baker, stocks technology, $aapl, $ionq, stocks defense, drops, $laes, hardware, about to, agencies, $adhclets, pultegroup inc, stocks consumer cyclical, $phm, over the, stocks, $abcl, $mrna, $ptct, $agio, $bbio, $stok, biogen inc, $biib, $tlry, $tpb, $cgc, $mjna, $gmab, $bcrx, $510b, $roiv, $gmed, $cldx, morgan stanley, stocks financial services, morgan, $166m, $1493k, $154m, $1246k, launchcoin, coins meme, $cnta, $tak, $zyme
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$BMRN $GMAB $BCRX $JAZZ: I like what they did this year so far. It should be the case for $NBIX $MDGL $EXEL .etc to follow with such deals. Thanks"
X Link @a_a_free 2025-10-14T11:11Z XXX followers, XXX engagements
"$ADHC-.0016 up that falls we will be 002s after news updates rumored to be coming this WEEK FDA pending approval one step closer. float at dtc unchanged for weeks=no dilution $pfe $jnj $mrk $abt $dxcm $rckt $mdgl $eltp $mreo $qnrx $ormp $crbp $enta $telo $teva $regn $ino $jazz $wst $oric $lipo $abos $ $rxrx $auph $alny $nvo $bmrn #diabetes #fda"
X Link @mikeycolombia33 2025-10-13T17:02Z 1677 followers, XXX engagements
"$ADHC-.0016 up BREAKOUT IMMINENT .NEWS EXPECTED THIS WEEK $pfe $jnj $mrk $abt $dxcm $rckt $mdgl $eltp $mreo $qnrx $ormp $crbp $enta $telo $teva $regn $ino $jazz $wst $oric $lipo $abos $ $rxrx $auph $alny $nvo $bmrn #diabetes #fda"
X Link @mikeycolombia33 2025-10-13T16:53Z 1677 followers, XXX engagements
"$ADHC-.0016 now UP BREAKOUT IMMINENT FDA pending approval .NEWS EXPECTED THIS WEEK LOOK at MM squirm trying to cover his short from higher levels.make him cover at ask up to XXX :) $pfe $jnj $mrk $abt $dxcm $rckt $mdgl $eltp $mreo $qnrx $ormp $crbp $enta $telo $teva $regn $ino $jazz $wst $oric $lipo $abos $ $rxrx $auph $alny $nvo $bmrn #diabetes #fda"
X Link @mikeycolombia33 2025-10-13T16:49Z 1678 followers, XXX engagements